IL165902A0 - Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same - Google Patents
Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the sameInfo
- Publication number
- IL165902A0 IL165902A0 IL16590204A IL16590204A IL165902A0 IL 165902 A0 IL165902 A0 IL 165902A0 IL 16590204 A IL16590204 A IL 16590204A IL 16590204 A IL16590204 A IL 16590204A IL 165902 A0 IL165902 A0 IL 165902A0
- Authority
- IL
- Israel
- Prior art keywords
- panroprazole
- hydrates
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 150000004677 hydrates Chemical class 0.000 title 1
- 159000000003 magnesium salts Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002134617 DE10234617B4 (de) | 2002-07-29 | 2002-07-29 | Neues Salz von (S)-Pantoprazol |
| EP02027275 | 2002-12-06 | ||
| EP03012411 | 2003-05-30 | ||
| PCT/EP2003/008269 WO2004013126A1 (en) | 2002-07-29 | 2003-07-26 | Salt of (s)-pantoprazole and its hydrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165902A0 true IL165902A0 (en) | 2006-01-15 |
Family
ID=31498922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16590204A IL165902A0 (en) | 2002-07-29 | 2004-12-21 | Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7629361B2 (de) |
| EP (1) | EP1527066B1 (de) |
| JP (1) | JP2006501313A (de) |
| KR (1) | KR20050025635A (de) |
| CN (1) | CN1312150C (de) |
| AR (1) | AR040666A1 (de) |
| AU (1) | AU2003266956B2 (de) |
| BR (1) | BR0312996A (de) |
| CA (1) | CA2493326C (de) |
| ES (1) | ES2415658T3 (de) |
| HR (1) | HRP20050155A2 (de) |
| IL (1) | IL165902A0 (de) |
| MX (1) | MXPA05001168A (de) |
| NO (1) | NO20050864L (de) |
| PL (1) | PL373163A1 (de) |
| TW (1) | TW200410955A (de) |
| WO (1) | WO2004013126A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2510849A1 (en) * | 2002-12-19 | 2004-07-08 | Teva Pharmaceutical Industries Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
| WO2004111029A2 (en) | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| WO2005012289A1 (en) * | 2003-07-17 | 2005-02-10 | Altana Pharma Ag | Novel salt of (r) - pantoprazole |
| US20080234326A1 (en) * | 2004-01-28 | 2008-09-25 | Altana Pharma Ag | Novel Salts of Pantoprazole and (S) - Pantoprazole |
| ES2376466T3 (es) * | 2004-05-07 | 2012-03-14 | Nycomed Gmbh | Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación. |
| ES2259269B1 (es) | 2005-03-03 | 2007-11-01 | Esteve Quimica, S.A. | Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos. |
| EP1747776A1 (de) * | 2005-07-29 | 2007-01-31 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmazeutische Zubereitung mit granulatförmigem Pantoprazol |
| US20080177076A1 (en) * | 2006-11-06 | 2008-07-24 | Lilach Hedvanti | Processes for preparing substantially pure pantoprazole magnesium |
| WO2009074997A2 (en) * | 2007-12-10 | 2009-06-18 | Lee Pharma Ltd. | A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate |
| CN102584790B (zh) * | 2011-12-31 | 2014-04-02 | 江苏奥赛康药业股份有限公司 | 一种s－泮托拉唑钠三水合物及其制备和应用 |
| CA2865845C (en) * | 2012-03-14 | 2020-02-18 | Vanda Pharmaceuticals Inc. | An iloperidone metabolite for use in the treatment of psychiatric disorders |
| JP2025532389A (ja) | 2022-10-04 | 2025-09-29 | ザビリュク，アルセニー | 大動脈弁の石灰化の抑制 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| FI90544C (fi) | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
| DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
| JPH08509738A (ja) | 1993-04-27 | 1996-10-15 | セプラコー，インコーポレイテッド | 光学的に純粋な（＋）パントプラゾールを用いる胃の疾患治療の方法と組成 |
| EP0695123A4 (de) | 1993-04-27 | 1996-09-11 | Sepracor Inc | Verfahren und zusammensetzungen zur behandlung gastrischer störungen unter verwendung optisch reinen pantoprazols |
| US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| TW359614B (en) | 1993-08-31 | 1999-06-01 | Takeda Chemical Industries Ltd | Composition containing benzimidazole compounds for rectal administration |
| SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
| SE9500478D0 (sv) | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
| SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| SE508669C2 (sv) * | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
| TW385306B (en) | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
| SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| SE9704869D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
| DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
-
2003
- 2003-07-07 TW TW092118493A patent/TW200410955A/zh unknown
- 2003-07-23 AR AR20030102638A patent/AR040666A1/es not_active Application Discontinuation
- 2003-07-26 HR HR20050155A patent/HRP20050155A2/hr not_active Application Discontinuation
- 2003-07-26 ES ES03747866T patent/ES2415658T3/es not_active Expired - Lifetime
- 2003-07-26 PL PL03373163A patent/PL373163A1/xx not_active Application Discontinuation
- 2003-07-26 CA CA2493326A patent/CA2493326C/en not_active Expired - Fee Related
- 2003-07-26 BR BR0312996-9A patent/BR0312996A/pt not_active IP Right Cessation
- 2003-07-26 EP EP03747866A patent/EP1527066B1/de not_active Expired - Lifetime
- 2003-07-26 MX MXPA05001168A patent/MXPA05001168A/es active IP Right Grant
- 2003-07-26 WO PCT/EP2003/008269 patent/WO2004013126A1/en not_active Ceased
- 2003-07-26 CN CNB038173433A patent/CN1312150C/zh not_active Expired - Fee Related
- 2003-07-26 US US10/489,659 patent/US7629361B2/en not_active Expired - Fee Related
- 2003-07-26 KR KR1020057001088A patent/KR20050025635A/ko not_active Withdrawn
- 2003-07-26 AU AU2003266956A patent/AU2003266956B2/en not_active Ceased
- 2003-07-26 JP JP2005506067A patent/JP2006501313A/ja not_active Withdrawn
-
2004
- 2004-12-21 IL IL16590204A patent/IL165902A0/xx unknown
-
2005
- 2005-02-17 NO NO20050864A patent/NO20050864L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050155A2 (en) | 2005-12-31 |
| AU2003266956A1 (en) | 2004-02-23 |
| AU2003266956B2 (en) | 2010-01-21 |
| CA2493326C (en) | 2012-09-18 |
| US20040248940A1 (en) | 2004-12-09 |
| JP2006501313A (ja) | 2006-01-12 |
| EP1527066A1 (de) | 2005-05-04 |
| WO2004013126A1 (en) | 2004-02-12 |
| ES2415658T3 (es) | 2013-07-26 |
| CA2493326A1 (en) | 2004-02-12 |
| NO20050864L (no) | 2005-02-17 |
| HK1077059A1 (en) | 2006-02-03 |
| EP1527066B1 (de) | 2013-03-27 |
| US7629361B2 (en) | 2009-12-08 |
| CN1312150C (zh) | 2007-04-25 |
| KR20050025635A (ko) | 2005-03-14 |
| BR0312996A (pt) | 2005-06-28 |
| TW200410955A (en) | 2004-07-01 |
| PL373163A1 (en) | 2005-08-22 |
| AR040666A1 (es) | 2005-04-13 |
| MXPA05001168A (es) | 2005-05-16 |
| CN1671691A (zh) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164987A (en) | Proline derivatives and pharmaceutical compositions containing the same | |
| IL173639A (en) | Ppar-activating compound and pharmaceutical composition containing same | |
| IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL173602A0 (en) | Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same | |
| IL173627A0 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same | |
| IL174128A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
| IL166482A0 (en) | Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same | |
| IL173051A0 (en) | N-glucoside derivatives and pharmaceutical compositions containing the same | |
| IL166129A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL171997A0 (en) | Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL163117A (en) | Indazole derivatives and pharmaceutical compositions containing the same | |
| IL164209A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL166620A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL175214A0 (en) | 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same | |
| SI1354873T1 (en) | Salt of perindopril and pharmaceutical compositions containing it | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| IL172159A0 (en) | 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same | |
| IL197889A (en) | Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same | |
| IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
| SI1664050T1 (sl) | Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te | |
| IL174445A0 (en) | Substituted isoquinolinone derivatives and pharmaceutical compositions containing the same | |
| IL174249A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same |